Exscientia | Results Presentation Deck | 33 slides — playbook

Exscientia | Results Presentation Deck | 33 slides

Exscientia · 2022-05

arc beats above · slides in the middle · loops below · scroll → 0 LOOPS

Deck intelligence map

6

coverage by narrative range · generated from this deck JSON

Narrative range 24 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Setup 4 slides 100% 4/4 slides 100% 4/4 slides · 19 hits

— 0/4 slides

25% 1/4 slides · 2 hits

— 0/4 slides

100% 4/4 slides

— 0/4 slides

Complication 3 slides 100% 3/3 slides 100% 3/3 slides · 12 hits

— 0/3 slides

100% 3/3 slides · 4 hits 100% 3/3 slides 100% 3/3 slides · 5 hits

— 0/3 slides

Propose Solution 4 slides 100% 4/4 slides 100% 4/4 slides · 16 hits

— 0/4 slides

75% 3/4 slides · 4 hits 75% 3/4 slides 100% 4/4 slides · 6 hits

— 0/4 slides

Evidence 4 slides 100% 4/4 slides 100% 4/4 slides · 23 hits

— 0/4 slides

75% 3/4 slides · 4 hits 50% 2/4 slides 100% 4/4 slides

— 0/4 slides

Roadmap 7 slides 100% 7/7 slides 100% 7/7 slides · 34 hits

— 0/7 slides

57.1% 4/7 slides 85.7% 6/7 slides 100% 7/7 slides

— 0/7 slides

Key Takeaways 2 slides 100% 2/2 slides 100% 2/2 slides · 10 hits

— 0/2 slides

50% 1/2 slides

— 0/2 slides

100% 2/2 slides

— 0/2 slides

Slide inventory

33

every slide · same image gating as the playbook

01

Features a network-style graphic representing complex data relationships.front_matter

Open slide detailBeat · Setup

02

other

Open slide detailBeat · Setup

03

summarize

Open slide detailBeat · Setup

04

front_matter

Open slide detailBeat · Setup

05

The slide acts as a portfolio or 'proof points' page, showcasing external validation through published research.illustrate_case

Open slide detail

06

The slide uses a simple linear process flow to establish the baseline context for the presentation.frame_situation

Open slide detailBeat · Complication

07

The slide uses a circular process flow to represent a continuous improvement or learning loop in pharmaceutical R&D.present_solution

Open slide detailBeat · Complication

08

The slide uses a process flow diagram to link preclinical models to the drug development pipeline.diagnose_problem

Open slide detailBeat · Complication

09

present_solution

Open slide detailBeat · Propose Solution

10

The diagram uses a central human silhouette to emphasize patient-centricity in the R&D lifecycle.present_framework

Open slide detailBeat · Propose Solution

11

transition

Open slide detailBeat · Evidence

12

The slide uses a circular process diagram to show the diagnostic workflow and a timeline/bar chart to show the treatment sequence.illustrate_case

Open slide detailBeat · Evidence

13

The slide uses a process flow to illustrate the patient journey from diagnosis to remission.illustrate_case

Open slide detailBeat · Evidence

14

Kaplan-Meier survival curves comparing matched vs non-matched treatments.analyze_data

Open slide detailBeat · Evidence

15

The slide uses a linear process flow to explain a clinical research methodology.plan_implementation

Open slide detailBeat · Roadmap

16

transition

Open slide detailBeat · Roadmap

17

The slide uses a visual comparison to contrast 'Previous approaches' (which fail to distinguish between selective and non-selective drug activity) with 'Exscienpresent_solution

Open slide detailBeat · Roadmap

18

The slide uses a circular process flow to represent the R&D pipeline.present_solution

Open slide detailBeat · Roadmap

19

The diagram uses a grid-like connection to represent the transformation process.present_solution

Open slide detailBeat · Roadmap

20

The slide uses a combination of a neural network diagram, a scatter plot (embedding), and a line chart to demonstrate the methodology.analyze_data

Open slide detailBeat · Roadmap

21

The slide uses a horizontal bar chart to represent progress through three stages: Assay Development, Biological Validation, and Clinical Testing.plan_implementation

Open slide detailBeat · Roadmap

22

transition

Open slide detail

23

The slide uses a visual process flow to explain target identification.present_solution

Open slide detail

24

The slide presents a high-dimensional dataset linking drug response (heatmap) to molecular targets (network graph).analyze_data

Open slide detail

25

transition

Open slide detail

26

The slide uses box plots to show dose-response curves for cancer (EpCAM) and immune (CD45) cells at 48 and 72 hours.analyze_data

Open slide detail

27

transition

Open slide detail

28

The chart is a mirrored bar chart showing positive drug response (cancer cell killing) vs negative drug response (non-cancerous cell killing) correlated with Geanalyze_data

Open slide detail

29

The slide uses a small multiples approach to show individual patient responses across time points and concentrations, highlighting a clear difference in sensitianalyze_data

Open slide detailBeat · Key Takeaways

30

The slide highlights the complexity of biomarker discovery, noting that published gene signatures do not always correlate with functional activity.analyze_data

Open slide detailBeat · Key Takeaways

31

transition

Open slide detail

32

The slide uses a circular process flow centered on a human silhouette to represent the application of technology across the drug discovery lifecycle.present_framework

Open slide detail

33

appendix

Open slide detail